Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
16
×
national blog main
san francisco blog main
16
×
life sciences
national top stories
san francisco top stories
boston blog main
boston top stories
new york blog main
national
new york top stories
san diego blog main
san diego top stories
detroit blog main
detroit top stories
raleigh-durham blog main
texas top stories
wisconsin blog main
boulder/denver blog main
boulder/denver top stories
raleigh-durham top stories
seattle blog main
seattle top stories
texas blog main
wisconsin top stories
fda
indiana blog main
indiana top stories
cancer
gene editing
boston
clinical trials
san francisco
cancer immunotherapy
ceo
checkpoint inhibitors
clinical study
commissioner
crispr-cas9
deals
What
medicine
16
×
cancer
treatment
bio
drug
gene
nobel
patients
prize
roundup
study
week
based
big
cas
company
crispr
editas
editing
fda
fight
goes
help
isn't
long
marketing
morning
precise
startup
therapeutics
u.s
acquire
adapt
ago
agreed
allison
alnylam
alzheimer's
amgen
amgen’s
Language
unset
Current search:
medicine
×
biotech
×
" san francisco blog main "
×
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
Amgen’s Osteoporosis Drug Wins European Nod, With a Heart Warning
@xconomy.com
4 years ago
Liquid Biopsy Firm Lucence Plans Bay Area Buildout With $20M in Tow
@xconomy.com
4 years ago
Bio Roundup: Nobel Prizes, Placebo Effect Rises, ICER’s Fire & More
@xconomy.com
4 years ago
Nobel Prize in Medicine Goes to 3 Who Showed How Cells Sense Oxygen Levels
@xconomy.com
4 years ago
Encoded Nabs $104M, Illumina’s Help, to Push Gene Therapy’s Limits
@xconomy.com
5 years ago
Can Tiny Drug Doses (and One Woman’s Fortune) Fight the Most Vicious Cancer?
@xconomy.com
5 years ago
In Landmark Gene-Editing Study, Sangamo Reports Little Benefit
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@xconomy.com
5 years ago
Bio Roundup: $74B for Celgene, Two CAR-T Tales, Ready for SF & More
@xconomy.com
5 years ago
Nobel Medicine Prize Honors Cancer Immunotherapy Pioneers Allison & Honjo
@xconomy.com
5 years ago
Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision
@xconomy.com
5 years ago
In a Genentech Redux, Roche Pays $2.4B for Rest of Foundation Medicine
@xconomy.com
6 years ago
Pfizer, Merck Lead Strata Oncology’s $26M Series B Round
@xconomy.com
6 years ago
Beam Therapeutics Spotlights CRISPR 2.0 with Precise Gene Editor, $87M
@xconomy.com
6 years ago
Will New Study Cut Guesswork for Depression Medicine Prescriptions?